Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

214 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial.
Ringelstein EB, Thijs V, Norrving B, Chamorro A, Aichner F, Grond M, Saver J, Laage R, Schneider A, Rathgeb F, Vogt G, Charissé G, Fiebach JB, Schwab S, Schäbitz WR, Kollmar R, Fisher M, Brozman M, Skoloudik D, Gruber F, Serena Leal J, Veltkamp R, Köhrmann M, Berrouschot J; AXIS 2 Investigators. Ringelstein EB, et al. Among authors: brozman m. Stroke. 2013 Oct;44(10):2681-7. doi: 10.1161/STROKEAHA.113.001531. Epub 2013 Aug 20. Stroke. 2013. PMID: 23963331 Clinical Trial.
Role of preexisting disability in patients treated with intravenous thrombolysis for ischemic stroke.
Karlinski M, Kobayashi A, Czlonkowska A, Mikulik R, Vaclavik D, Brozman M, Svigelj V, Csiba L, Fekete K, Kõrv J, Demarin V, Vilionskis A, Jatuzis D, Krespi Y, Ahmed N, Wahlgren N; Safe Implementation of Treatments in Stroke–Eastern Europe (SITS-EAST) Investigators. Karlinski M, et al. Among authors: brozman m. Stroke. 2014 Mar;45(3):770-5. doi: 10.1161/STROKEAHA.113.003744. Epub 2014 Feb 4. Stroke. 2014. PMID: 24496395
Intravenous Thrombolysis for Stroke Recurring Within 3 Months From the Previous Event.
Karlinski M, Kobayashi A, Czlonkowska A, Mikulik R, Vaclavik D, Brozman M, Gdovinova Z, Švigelj V, Csiba L, Fekete K, Kõrv J, Demarin V, Bašic-Kes V, Vilionskis A, Jatuzis D, Krespi Y, Shamalov N, Andonova S, Ahmed N, Wahlgren N; Safe Implementation of Treatments in Stroke–East Registry (SITS-EAST) Investigators. Karlinski M, et al. Among authors: brozman m. Stroke. 2015 Nov;46(11):3184-9. doi: 10.1161/STROKEAHA.115.010420. Epub 2015 Oct 8. Stroke. 2015. PMID: 26451024
Factors influencing in-hospital delay in treatment with intravenous thrombolysis.
Mikulík R, Kadlecová P, Czlonkowska A, Kobayashi A, Brozman M, Svigelj V, Csiba L, Fekete K, Kõrv J, Demarin V, Vilionskis A, Jatuzis D, Krespi Y, Ahmed N; Safe Implementation of Treatments in Stroke-East Registry (SITS-EAST) Investigators. Mikulík R, et al. Among authors: brozman m. Stroke. 2012 Jun;43(6):1578-83. doi: 10.1161/STROKEAHA.111.644120. Epub 2012 Mar 15. Stroke. 2012. PMID: 22426311 Clinical Trial.
Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke: An Exploratory Analysis of the THALES Randomized Clinical Trial.
Wang Y, Pan Y, Li H, Amarenco P, Denison H, Evans SR, Himmelmann A, James S, Birve F, Ladenvall P, Molina CA, Johnston SC; THALES Steering Committee and Investigators. Wang Y, et al. JAMA Neurol. 2021 Sep 1;78(9):1091-1098. doi: 10.1001/jamaneurol.2021.2440. JAMA Neurol. 2021. PMID: 34244703 Free PMC article. Clinical Trial.
Benefit of thrombolysis for stroke is maintained around the clock: results from the SITS-EAST Registry.
Kõrv J, Vibo R, Kadlecová P, Kobayashi A, Czlonkowska A, Brozman M, Švigelj V, Csiba L, Fekete K, Demarin V, Vilionskis A, Jatuzis D, Krespi Y, Ahmed N, Mikulík R; Safe Implementation of Treatments in Stroke - East Registry Investigators. Kõrv J, et al. Among authors: brozman m. Eur J Neurol. 2014;21(1):112-7. doi: 10.1111/ene.12257. Epub 2013 Sep 16. Eur J Neurol. 2014. PMID: 24102712
214 results